Angie Read: Stories of Strength and Resilience on The Latest Episode of Stroke Sisters
Angie Read, Founder and CEO of Stroke Sisters, MarComm Manager – Member Acquisition and Engagement at American Academy of Family Physicians, shared on LinkedIn:
”One of the most meaningful parts of building the Stroke Sisters ecosystem has been the opportunity to connect with survivors from all over the world and help elevate their stories.
I’m excited to share the latest episode of the ‘Stroke Sisters: Stories of Strength and Resilience’ podcast, featuring Lola White, a stroke survivor and Vivistim patient, along with Nicole Goldstein from Vivistim.
Lola speaks candidly about rebuilding after stroke, navigating shifts in identity and ambition, and finding purpose in this next chapter of life.
We also discuss Vivistim therapy and how it’s helping some ischemic stroke survivors improve hand and arm function by supporting neuroplasticity.
Interested in learning more about this breakthrough vagus nerve stimulation therapy?
This episode is the first in a special series we’re producing this year with Vivistim, centered on authentic survivor experiences and meaningful conversations around recovery.”
Stay updated with Hemostasis Today.
-
May 23, 2026, 07:30Ozlem Fidanci: Reflections From WHA79 on the Future of Stroke Care
-
May 23, 2026, 07:21Ney Carter Borges: Where the Benefit Appears in Dual Antiplatelet Therapy
-
May 23, 2026, 05:38SIUH Advances Precision Stroke Care with Vena MicroAngioscope – Northwell Health
-
May 23, 2026, 05:31Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia
-
May 23, 2026, 05:29Understanding Hepatitis A, B, and C During Hepatitis Awareness Month – UNC Health
-
May 23, 2026, 03:55WFH Initiative Brings Hope to the Hemophilia Community in India
-
May 23, 2026, 03:47Satyam Arora: Welcoming the New ISBT Board for the 2026 Term
-
May 23, 2026, 03:33Brig Tathagata Chatterjee: Connecting With World Leaders in Hematology at ISH Congress
-
May 23, 2026, 03:18Mathangi Kumar: Dental Management Strategies for Congenital Hemophilia